BioSpace News Archive

DaVita Clinical Research (DCR) will present 14 research abstracts from company representatives and medical professionals at the American Society of Nephrology (ASN) annual Kidney Week occurring Oct. 22–25, 2020.

GYANT, the AI-powered virtual assistant company, today announced that Justin Graham, MD, MS, has joined the company as Chief Medical Officer (CMO)

Enzolytics, Inc. (OTC PINK:ENZC) announced the appointment, by the Board of Directors of the Company, on October 20 of Charles Cotropia to the position of CEO of Enzolytics.

Today, IAVI, a nonprofit scientific research organization dedicated to addressing urgent, unmet global health challenges, and Serum Institute of India Pvt. Ltd., a leading manufacturer of vaccines and biologics, announced an agreement with Merck KGaA, Darmstadt, Germany, a leading science and technology company, to develop SARS-CoV-2 neutralizing monoclonal antibodies (mAbs) co-invented by IAVI and Scripps Research

BELLUS Health Inc. announced that it has completed its previously-announced underwritten public offering in Canada and the United States of 17,888,889 common shares at a price to the public of US$2.25 per common share, which includes the exercise in full of the underwriters’ option to purchase additional common shares.

Relievant Medsystems, a privately-held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), today announced the North American Spine Society Journal publicationi of results from an effectiveness study showing that the significant improvements in function and pain initially reported at an interim analysis of three monthsii following the Intracept Procedure remained significant through one year.

Radiation Therapy clinics and departments worldwide report the SunCHECK™ Platform from Sun Nuclear has proven essential to their COVID-19 preparedness.

Breakthrough enables hospitals to expand the capacity of imaging and biomedical equipment teams; and quickly procure expert service using online platform trusted by 3,500 hospitals

Micro-Tech Endoscopy USA reveals their latest product launch in the GI market, EndoINK Endoscopic Marker. EndoINK is a single-use fluid designed to endoscopically mark lesions in the gastrointestinal tract

Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), hereafter “Onxeo” or “the Company”, a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA Damage response (DDR), in particular against rare or resistant cancers, today announced that it has received from the European Patent Office (EPO) a notice of intent to grant a patent which strengthens the protection in Europe of AsiDNA